Nishikawa et al. (37) suggested that mutant KRAS-induced HES-1 played an essential role in the initiation and progression of pancreatic ductal adenocarcinoma by regulating acinar-to-ductal reprogramming-related genes. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.